Detalhe da pesquisa
1.
Blockade of NMT1 enzymatic activity inhibits N-myristoylation of VILIP3 protein and suppresses liver cancer progression.
Signal Transduct Target Ther
; 8(1): 14, 2023 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36617552
2.
ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis.
Cancer Res
; 83(11): 1851-1865, 2023 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36912612
3.
Lysine 2-hydroxyisobutyrylation of NAT10 promotes cancer metastasis in an ac4C-dependent manner.
Cell Res
; 33(5): 355-371, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36882514
4.
Lysine butyrylation of HSP90 regulated by KAT8 and HDAC11 confers chemoresistance.
Cell Discov
; 9(1): 74, 2023 Jul 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37460462
5.
Blockade of Nuclear ß-Catenin Signaling via Direct Targeting of RanBP3 with NU2058 Induces Cell Senescence to Suppress Colorectal Tumorigenesis.
Adv Sci (Weinh)
; 9(34): e2202528, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36270974
6.
Anti-HIV Drug Elvitegravir Suppresses Cancer Metastasis via Increased Proteasomal Degradation of m6A Methyltransferase METTL3.
Cancer Res
; 82(13): 2444-2457, 2022 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35507004
7.
Targeting PI3K/Akt signal transduction for cancer therapy.
Signal Transduct Target Ther
; 6(1): 425, 2021 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34916492